GlassScriptPhysician profile
Eric W Bussear
NPI 1336160258
$22,963.80
in general payments reported to CMS, 2019-2025
23 companies · $851 in 2025
The $851 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11K · 2022: $11K · 2023: $17.76 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15,916.11 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $2,586.78 | 2021-2025 | |
| Ucb, INC. | $2,342.64 | 2021-2025 | Bimzelx |
| Pfizer INC. | $428.70 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $314.40 | 2021-2025 | |
| Incyte Corporation | $271.96 | 2021-2022 | |
| Janssen Biotech, INC. | $247.20 | 2021-2022 | |
| Lilly USA, LLC | $176.95 | 2021-2025 | Ebglyss, Taltz |
| Genzyme Corporation | $128.45 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $78.25 | 2021 | |
| Amgen INC. | $70.12 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.37 | 2022 | |
| Vyne Pharmaceuticals INC. | $46.42 | 2021 | |
| Paratek Pharmaceuticals, INC. | $44.87 | 2025 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.51 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $39.16 | 2022 | |
| Galderma Laboratories, L.P. | $38.64 | 2025 | Nemluvio |
| Helsinn Therapeutics (U.S.), INC. | $31.37 | 2021 | |
| Biofrontera INC. | $28.34 | 2021-2025 | Bf-Rhodoled |
| Organon LLC | $28.19 | 2025 | |
| Almirall LLC | $22.00 | 2021 | |
| Organogenesis INC. | $17.98 | 2021 | |
| Botanix Sb INC | $14.39 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bussear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.